{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:09:26Z","timestamp":1779908966203,"version":"3.53.1"},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"3","funder":[{"name":"Shizuoka Children\u2019s Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0457","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T22:10:14Z","timestamp":1733263814000},"page":"333-340","source":"Crossref","is-referenced-by-count":3,"title":["Glutamic acid decarboxylase antibody-spectrum disorders and type 1 diabetes mellitus in a patient following allogenic hematopoietic cell transplantation with review of literature"],"prefix":"10.1507","volume":"72","author":[{"given":"Shinichiro","family":"Sano","sequence":"first","affiliation":[{"name":"Department of Diabetes and Metabolism, Shizuoka Children\u2019s Hospital, Shizuoka 420-8660, Japan"},{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taemi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shizuoka Children\u2019s Hospital, Shizuoka 420-8660, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Takachi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shizuoka Children\u2019s Hospital, Shizuoka 420-8660, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolism, Shizuoka Children\u2019s Hospital, Shizuoka 420-8660, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-9991","authenticated-orcid":false,"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"},{"name":"Department of Pediatrics, Hamamatsu Medical Center, Hamamatsu 432-8580, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shizuoka Children\u2019s Hospital, Shizuoka 420-8660, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Epilepsy, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka 420-8688, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Gagnon MM, Savard M (2016) Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci 43: 486\u2013493.","DOI":"10.1017\/cjn.2016.13"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Wendt A, Birnir B, Buschard K, Gromada J, Salehi A, et al. (2004) Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 53: 1038\u20131045.","DOI":"10.2337\/diabetes.53.4.1038"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kawasaki E (2014) Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol 23: 99\u2013105.","DOI":"10.1297\/cpe.23.99"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, et al. (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318: 1012\u20131020.","DOI":"10.1056\/NEJM198804213181602"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Dalakas MC (2022) Stiff-person Syndrome and GAD Antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies. Neurotherapeutics 19: 832\u2013847.","DOI":"10.1007\/s13311-022-01188-w"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bai L, Ren H, Liang M, Lu Q, Lin N, et al. (2022) Neurological disorders associated with glutamic acid decarboxylase 65 antibodies: Clinical spectrum and prognosis of a cohort from China. Front Neurol 13: 990553.","DOI":"10.3389\/fneur.2022.990553"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Heneberg P (2023) Diabetes in stiff-person syndrome. Trends Endocrinol Metab 34: 640\u2013651.","DOI":"10.1016\/j.tem.2023.07.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, et al. (2015) Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant 21: 142\u2013150.","DOI":"10.1016\/j.bbmt.2014.10.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, et al. (2013) Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol 31: 2437\u20132449.","DOI":"10.1200\/JCO.2012.46.6193"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gabriel M, Hoeben BAW, Uhlving HH, Zajac-Spychala O, Lawitschka A, et al. (2021) A review of acute and long-term neurological complications following haematopoietic stem cell transplant for paediatric acute lymphoblastic leukaemia. Front Pediatr 9: 774853.","DOI":"10.3389\/fped.2021.774853"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11 Dalakas MC, Li M, Fujii M, Jacobowitz DM (2001) Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 57: 780\u2013784.","DOI":"10.1212\/WNL.57.5.780"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tsiortou P, Alexopoulos H, Dalakas MC (2021) GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions. Ther Adv Neurol Disord 14: 17562864211003486.","DOI":"10.1177\/17562864211003486"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Disserol CCD, Kowacs DP, Nabhan SK, Teive HAG, Kowacs PA (2023) Case report: successful autologous hematopoietic stem cell transplantation in a patient with GAD antibody-spectrum disorder with rapidly progressive dementia. Front Neurol 14: 1254981.","DOI":"10.3389\/fneur.2023.1254981"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 H\u00fcmmert MW, Stadler M, Hambach L, Gingele S, Bredt M, et al. (2021) Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation. Sci Rep 11: 8527.","DOI":"10.1038\/s41598-021-87989-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Madlener M, Strippel C, Thaler FS, Doppler K, Wandinger KP, et al. (2023) Glutamic acid decarboxylase antibody-associated neurological syndromes: clinical and antibody characteristics and therapy response. J Neurol Sci 445: 120540.","DOI":"10.1016\/j.jns.2022.120540"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mu\u00f1oz-Lopetegi A, de Bruijn M, Boukhrissi S, Bastiaansen AEM, Nagtzaam MMP, et al. (2020) Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm 7: e696.","DOI":"10.1212\/NXI.0000000000000696"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Graus F, Saiz A, Dalmau J (2020) GAD antibodies in neurological disorders - insights and challenges. Nat Rev Neurol 16: 353\u2013365.","DOI":"10.1038\/s41582-020-0359-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Teshima T, Boelens JJ, Matsuoka KI (2023) Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation. Blood Cell Ther 6: 42\u201348.","DOI":"10.31547\/bct-2022-023"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Watkins B, Williams KM (2022) Controversies and expectations for the prevention of GVHD: a biological and clinical perspective. Front Immunol 13: 1057694.","DOI":"10.3389\/fimmu.2022.1057694"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yamamura S, Fukui T, Mori Y, Hayashi T, Yamamoto T, et al. (2019) Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population. J Diabetes Investig 10: 1480\u20131489.","DOI":"10.1111\/jdi.13052"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Fourlanos S, Neal A, So M, Evans A (2014) Latent autoimmune diabetes in Stiff-Person Syndrome. Diabetes Care 37: e214\u2013e215.","DOI":"10.2337\/dc14-1444"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156: 818\u2013825.","DOI":"10.4049\/jimmunol.156.2.818"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23 Bj\u00f6rk E, Velloso LA, K\u00e4mpe O, Karlsson FA (1994) GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43: 161\u2013165.","DOI":"10.2337\/diabetes.43.1.161"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Clow EC, Couban S, Grant IA (2008) Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation. Muscle Nerve 38: 1649\u20131652.","DOI":"10.1002\/mus.21153"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, et al. (2019) Immune mediated cerebellar ataxia: an unknown manifestation of graft-<i>versus<\/i>-host disease. Acta Haematol 141: 19\u201322.","DOI":"10.1159\/000494423"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Nagai K, Maekawa T, Terashima H, Kubota M, Ishiguro A (2019) Severe anti-GAD antibody-associated encephalitis after stem cell transplantation. Brain Dev 41: 301\u2013304.","DOI":"10.1016\/j.braindev.2018.10.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Sequeira M, Lobo GG, Ferro M, Capela C (2024) Relapsing remitting encephalomyelitis with glutamic acid decarboxylase antibodies following autologous haematopoietic stem cell transplantation-coincidence or consequence? Neurol Sci 45: 813\u2013815.","DOI":"10.1007\/s10072-023-07134-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Rathore GS, Leung KS, Muscal E (2015) Autoimmune encephalitis following bone marrow transplantation. Pediatr Neurol 53: 253\u2013256.","DOI":"10.1016\/j.pediatrneurol.2015.05.011"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Lee YY, Chen IW, Chen ST, Wang CC (2019) Association of stiff-person syndrome with autoimmune endocrine diseases. World J Clin Cases 7: 2942\u20132952.","DOI":"10.12998\/wjcc.v7.i19.2942"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, et al. (2012) Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol 69: 230\u2013238.","DOI":"10.1001\/archneurol.2011.991"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, et al. (1997) Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Autoimmunity 25: 203\u2013211.","DOI":"10.3109\/08916939708994729"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Martino G, Grimaldi LM, Bazzigaluppi E, Passini N, Sinigaglia F, et al. (1996) The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients. J Neuroimmunol 69: 129\u2013134.","DOI":"10.1016\/0165-5728(96)00104-X"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33 Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, et al. (1994) Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43: 1254\u20131259.","DOI":"10.2337\/diabetes.43.10.1254"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/3\/72_EJ24-0457\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T03:23:19Z","timestamp":1741404199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/3\/72_EJ24-0457\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0457","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0457"}}